Table: begin end state 1 29 cytoplasmic 30 49 transmembrane 50 57 non-cytoplasmic 58 80 transmembrane 81 91 cytoplasmic 92 112 transmembrane 113 117 non-cytoplasmic 118 138 transmembrane 139 156 cytoplasmic 157 179 transmembrane 180 190 non-cytoplasmic 191 210 transmembrane 211 238 cytoplasmic 239 259 transmembrane 260 277 non-cytoplasmic 278 297 transmembrane 298 308 cytoplasmic 309 327 transmembrane 328 333 non-cytoplasmic 334 357 transmembrane 358 367 cytoplasmic 368 390 transmembrane 391 401 non-cytoplasmic 402 420 transmembrane 421 431 cytoplasmic
Input: >AO353_17220 FitnessBrowser__pseudo3_N2E3:AO353_17220 MTTITSLYTAEERGKRIFAIVGASSGNLVEWFDFYVYAFCAIYFAPAFFPSDNPTVQLVN TAGVFAAGFLMRPIGGWLFGRVADKHGRKNSMMISVLMMCAGSLLIACLPTYKDIGVWAP LLLLVARLIQGVSVGGEYGTTATYMSEVALKGQRGFFASFQYVTLIGGQLLAVSLVVILQ QFLTEDDLRAWGWRIPFVVGAAAALISLFLRRSLKETTSKEMRENKDAGSMAALFRNNTA AFITVLGFTAGGSLIFYTFTTYMQKYLVNTAGMPAKTASYIMTGALFLYMCMQPLFGTLA DKIGRRNSMLWFGALGTLFTVPILLTLKSVTNPFLAFGLITVALAIVSFYTSISGLVKAE MFPPQVRALGVGLAYAVANAIFGGSAEYVALSLKSVGIENSFYWYVTAMMAIAFLFSLRL PRQAAYLENEL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server